Market reaction of COVID-19 vaccine makers to U.S. support of vaccine patents waiver
As of May 2021, Moderna's share price decreased by seven percent as a reaction to the U.S. support of the WTO's proposed temporary waiver of COVID-19 vaccine patents. This statistic illustrates the early share price reaction of COVID-19 vaccine makers to U.S. support of temporarily wavering COVID-19 vaccine patents.